Zn(2+)/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases tumour necrosis factor alpha concentration
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Findingreplicated ×1“After the treatment period, the Zn-supplemented patients had significantly decreased concentrations of hs-CRP, TNF-α, and IL-1β compared to patients not receiving Zn supplementation.”
Quoted verbatim from Effects of zinc supplementation on plasma copper/zinc ratios, oxidative stress, and immunological status in hemodialysis patients.. - Study
- RCT
- Duration
- 8 weeks
- Dose
- 11 mg elemental Zn per day (78 mg Zn gluconate), after dinner
- Population
- Long-term hemodialysis patients with low plasma zinc, supplemented for eight weeks versus patients given no supplement
Effects of zinc supplementation on plasma copper/zinc ratios, oxidative stress, and immunological status in hemodialysis patients.2013PMID:23289009Permalink
Keep reading
- Everything the graph holds on Zn(2+)
- Every compound studied against Tumour necrosis factor alpha concentration
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M5KC8JH18HWXEV5XSPQ5Y3TZ